REQUEST A DEMO
Total
USD $0.00
Search more companies

Avalon Pharmaceutical Sa (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Avalon Pharmaceutical Sa Profile Updated: January 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

avalon pharmaceutical latam is headquartered in Bogotá, Colombia, and was established in 2010. avalon pharmaceutical latam operates in the area of healthcare. avalon pharmaceutical latam employs 11-50 people.

Headquarters
Cr 14 # 85 68 Of 402
Bogota D.C.; Bogota D.C; Postal Code: 0806

Contact Details: Purchase the Avalon Pharmaceutical Sa report to view the information.

Basic Information
Total Employees:
Purchase the Avalon Pharmaceutical Sa report to view the information.
Registered Capital:
Purchase the Avalon Pharmaceutical Sa report to view the information.
Financial Auditors:
Purchase the Avalon Pharmaceutical Sa report to view the information.
Incorporation Date:
July 08, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Avalon Pharmaceutical Sa report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
6.84%
Total operating revenue
-8.73%
Operating Profit/Loss (EBIT)
-9.69%
EBITDA
-6.77%
Net Profit/Loss for the Period
56.83%
Total Assets
4.33%
Total Equity
29.64%
Operating Profit Margin (ROS)
-1.77%
Net Profit Margin
1.89%
Return on Equity (ROE)
3.96%
Debt/Equity
-2.39%
Quick Ratio
0.01%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?